Neurocrine Biosciences
NBIX
#1669
Rank
NZ$21.72 B
Marketcap
NZ$216.01
Share price
-1.87%
Change (1 day)
20.72%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Cost to borrow NBIX shares - Neurocrine Biosciences

Latest borrow fee for Neurocrine Biosciences (NBIX) shares on Interactive Brokers: 0.2500% (annualized)

Shares available to borrow: 4000000

The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.

Neurocrine Biosciences (NBIX) - cost to borrow in the last 7 days chart

Neurocrine Biosciences (NBIX) - number of shares available to borrow in the last 7 days

Neurocrine Biosciences (NBIX) - cost to borrow from 2026 to 2023

Neurocrine Biosciences (NBIX) - number of shares available to borrow from 2026 to 2023

Cost to borrow for shares of similar companies or competitors

Company Cost to borrow (% year) Shares available Country
Pfizer
PFE
0.4081%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
0.4081%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
0.4081%9.2 M๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
0.4238%0.45 M๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
29.7439%1.6 M๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
0.2891%0.15 M๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
9.9362%0.04 M๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
0.4081%8 M๐Ÿ‡ฌ๐Ÿ‡ง UK